Bagougeramines A and B obtained as sulfates were soluble in water and positive to Sakaguchi, chlorine-tolidine and ninhydrin color reactions. Their structures were determined by acid hydrolysis and spectroscopic analysis. Structurally they were closely related to gougerotin and they contained the guanidine-D-alanine instead of the serine residue in gougerotin. Bagougeramine B had the spermidine instead of the 6'-NH2 in structure of bagougeramine A.
In the preceding papery, we reported that bagougeramines A and B which had antimicrobial and anti-mite activities were produced by Bacillus circulars TB-2125. The producer had unique physiological properties and the moving colonies on agar plate as described as "swarming".
In this report, we describe the physico-chemical properties and structural elucidation of bagougeramines A and B.
Results and Discussion
Physico-chemical Properties of Bagougeramines A and B As summarized in Table 1 , the sulfates of bagougeramines A (1) and B (2) isolated from the fermentation broth of B. circulans TB-21251) were white hygroscopic powders which were soluble in water and positive to Sakaguchi and chlorine-tolidine reactions. UV spectra (Fig. 2) of antibiotics showed the presence of N1-substituted cytosine nucleus in their structures. The IR spectra were shown in Their 1H and 13C NMR data were listed in Tables   2 and 3 .
Structures of Bagougeramines A and B
In the 1H NMR spectrum ( Acid hydrolysis of 2 (hydrochloride) with 6 N HCI at 100°C, followed by purification of its hydrolysate by column chromatographies on Sephadex LH-20 and Amberlite CG-50 (NH4+) gave compounds 3, 4, 5 and 6 (Fig. 4) . From these data, compound 6 was determined as guanidino-n-alanine. An authentic sample of guanidine-L-alanine hydrochloride (Sigma Chem., Co.) showed [a] 22D +14.6-(H2O). +14.6' (H2O). The absolute structure of compound 6 was confirmed by HPLC for enantiomeric resolution of amino acid4) in comparison with synthetic guanidine-DL-alanine5) and authentic L-enantiomer. Fig. 5 indicates that the peak of compound 6 (7.22 minutes) was superimposable with that of D-enantiomer while an authentic sample of L-enantiomer migrated at 7.90 minutes.
Comparing the 1H NMR spectrum of 2 with that of 3, H-4' signal in 2 shifted downfield from the corresponding signal in 3 (from 6 3.31 to 4.09, Table 2 ). The 1H NMR spectra of 2 in D2O at pD 8.8 showed that the N-methyl and methylene signals in a sarcosyl moiety shifted upfield by 0.37 and 0.51 ppm, respectively, compared with those at pD 5.0 (Table 2) . Therefore, compound 2 incorporated a sarcosyl (guanidine-D-alanyl) residue at the 4'-amino group.
Thus, the structure of bagougeramine B was determined to be 2 as shown in Fig. 1 .
By refluxing in 6 N HCl, compound 1 afforded three fragments, C-substance (3), sarcosine (5), and guanidine-D-alanine (6). The 1H and 11C NMR spectra of 1 were quite similar to those of 2 except for the lack of signals for the spermidine moiety. Thus, bagougeramine A was determined as shown in Fig. 1 .
These structural studies of bagougeramines A and B revealed that they were new cytosine-nucleoside antibiotics with an unusual amino acid, guanidine-D-alanine, in their structures and were structurally related to gougerotin6 -8 ( Fig. 1 ).
Experimental
Melting points were determined with a Yazawa melting point aparatus and were uncorrected. Optical rotation was measured with a Perkin-Elmer model 241 polarimeter. IR spectrum was re-corded with a Hitachi 260-10 infrared spectrophotometer.
The 1H and 13C NMR spectra were measured with Jeol JNM-GX400 spectrometer. TLC was performed on a silica gel (Kieselgel 60 F25 4, Merck) developed with a mixture of BuOH -AcOH -H2O(2: 1 : 1).
Acid Hydrolysis of 2 A solution of 2 (hydrochloride, 82 mg) in 8 ml of 6 N HCl was refluxed for 6 hours. The solution was diluted with 72 ml of H2O and neutralized with Amberlite IRA-45 (OH-).
After removal of solid, the aqueous solution was concentrated under reduced pressure to give a pale yellow solid. The residue was dissolved in I ml of 50% aq MeOH and applied to a column of Sephadex LH-20. The column was developed with 50% aq MeOH. The eluate was collected in 2.5 ml fractions. Fractions (Nos. 52 58) were combined and concentrated to give a solid (HL-A). The same procedures of fractions (Nos. 59 -63) gave a solid (HL-B) . A Solution of HL-A was passed through a column of Amberlite CG-50 (NH4+, 5 ml). The column was developed with H2O (2 ml fractions). Fractions (Nos. 3 -5) were combined and concentrated to dryness. The residue was applied again to a column of Sephadex LH-20 and eluted with 50% aq MeOH (1.25 ml fractions). Fractions (Nos. 90-93) were combined and concentrated to give a colorless solid, which was recrystallized from H2O -MeOH 
